Purple Biotech Ltd. (PPBT)
NASDAQ: PPBT
· Real-Time Price · USD
2.49
0.01 (0.40%)
At close: Jun 17, 2025, 3:36 PM
0.40% (1D)
| Bid | 2.42 |
| Market Cap | 6.59M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -7.24M |
| EPS (ttm) | 476.1 |
| PE Ratio (ttm) | 0.01 |
| Forward PE | -3.89 |
| Analyst | Buy |
| Ask | 2.49 |
| Volume | 24,820 |
| Avg. Volume (20D) | 105,590 |
| Open | 2.46 |
| Previous Close | 2.48 |
| Day's Range | 2.41 - 2.55 |
| 52-Week Range | 2.00 - 13.95 |
| Beta | -0.74 |
About PPBT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PPBT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PPBT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-5.14%
PPBT stock has given up its prior gain. Purple Bio...
Unlock content with
Pro Subscription
1 month ago
-5.14%
Purple Biotech shares are trading higher after the company's CM24 showed up to a 90% reduction in the death risk for pancreatic cancer patients and announced it will commence a Phase 2b study.
